China GLP-1 Receptor Agonist Market Insights Chinas large diabetic population and increasing obesity rates are driving growth in the countrys GLP-1 receptor agonist market
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout Subjects References Parker, J
Improves Bone Density: Weight-bearing exercise helps strengthen your bones, a crucial component of overall health as you age
Discover Liposomal Glutahtione travel packs with advanced liposomal delivery for superior absorption
Roma-Rodrigues C, Mendes R, Baptista PV, Fernandes AR
Biofilm microenvironment-responsive nanotheranostics for dual-mode imaging and hypoxia-relief-enhanced photodynamic therapy of bacterial infections